Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1606-1613

  Sandy, Ashley R ^a   Stoolman, Josh ^a   Malott, Kelli ^a   Pongtornpipat, Prae ^a   Segal, Benjamin M ^a   Maillard, Ivan ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNMAML PROTEIN; GAMMA INTERFERON; INTERLEUKIN 17; MYELIN; NOTCH RECEPTOR; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNIZATION; INCIDENCE; LOSS OF FUNCTION MUTATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MIGRATION INHIBITION; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NOTCH; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 84881456447     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301116     Document Type: Article

References (45)

1. Kopan, R., and M. X. Ilagan. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233.
2. Louvi, A., and S. Artavanis-Tsakonas. 2012. Notch and disease: a growing field. Semin. Cell Dev. Biol. 23: 473-480.
3. - dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664.
4. Klinakis, A., C. Lobry, O. Abdel-Wahab, P. Oh, H. Haeno, S. Buonamici, I. van De Walle, S. Cathelin, T. Trimarchi, E. Araldi, et al. 2011. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233.
5. Radtke, F., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H. R. MacDonald, and M. Aguet. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10: 547-558.
6. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3: 443-450.
7. + innate lymphoid cells. Nat. Immunol. 12: 949-958.
8. Wong, S. H., J. A. Walker, H. E. Jolin, L. F. Drynan, E. Hams, A. Camelo, J. L. Barlow, D. R. Neill, V. Panova, U. Koch, et al. 2012. Transcription factor RORα is critical for nuocyte development. Nat. Immunol. 13: 229-236.
9. Lee, J. S., M. Cella, K. G. McDonald, C. Garlanda, G. D. Kennedy, M. Nukaya, A. Mantovani, R. Kopan, C. A. Bradfield, R. D. Newberry, and M. Colonna. 2012. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13: 144-151.
10. Amsen, D., A. Antov, and R. A. Flavell. 2009. The different faces of Notch in Thelper-cell differentiation. Nat. Rev. Immunol. 9: 116-124.
11. Radtke, F., N. Fasnacht, and H. R. Macdonald. 2010. Notch signaling in the immune system. Immunity 32: 14-27.
12. Minter, L. M., D. M. Turley, P. Das, H. M. Shin, I. Joshi, R. G. Lawlor, O. H. Cho, T. Palaga, S. Gottipati, J. C. Telfer, et al. 2005. Inhibitors of γ-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6: 680-688.
13. Jurynczyk, M., A. Jurewicz, B. Bielecki, C. S. Raine, and K. Selmaj. 2008. Overcoming failure to repair demyelination in EAE: γ-secretase inhibition of Notch signaling. J. Neurol. Sci. 265: 5-11.
14. Jurynczyk, M., A. Jurewicz, B. Bielecki, C. S. Raine, and K. Selmaj. 2005. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J. Neuroimmunol. 170: 3-10.
15. Jurynczyk, M., A. Jurewicz, C. S. Raine, and K. Selmaj. 2008. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase Cθ and attenuates experimental autoimmune encephalomyelitis. J. Immunol. 180: 2634-2640.
16. Bassil, R., B. Zhu, Y. Lahoud, L. V. Riella, H. Yagita, W. Elyaman, and S. J. Khoury. 2011. Notch ligand Delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. J. Immunol. 187: 2322-2328.
17. Reynolds, N. D., N. W. Lukacs, N. Long, and W. J. Karpus. 2011. Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis. J. Immunol. 187: 2803-2813.
18. Eixarch, H., M. J. Mansilla, C. Costa, S. L. Kunkel, X. Montalban, N. Godessart, and C. Espejo. 2013. Inhibition of Delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis. Neurosci. Lett. 541: 161-166.
19. Elyaman, W., R. Bassil, E. M. Bradshaw, W. Orent, Y. Lahoud, B. Zhu, F. Radtke, H. Yagita, and S. J. Khoury. 2012. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36: 623-634.
20. Gaiano, N., and G. Fishell. 2002. The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci. 25: 471-490.
21. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
22. McCright, B., J. Lozier, and T. Gridley. 2006. Generation of new Notch2 mutant alleles. Genesis 44: 29-33.
23. Tu, L., T. C. Fang, D. Artis, O. Shestova, S. E. Pross, I. Maillard, and W. S. Pear. 2005. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202: 1037-1042.
24. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
25. Mukherjee, S., M. A. Schaller, R. Neupane, S. L. Kunkel, and N. W. Lukacs. 2009. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J. Immunol. 182: 7381-7388.
26. H1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
27. Shin, H. M., L. M. Minter, O. H. Cho, S. Gottipati, A. H. Fauq, T. E. Golde, G. E. Sonenshein, and B. A. Osborne. 2006. Notch1 augments NF-κB activity by facilitating its nuclear retention. EMBO J. 25: 129-138.
28. 7-integrin. J. Clin. Invest. 102: 2096-2105.
29. Buonamici, S., T. Trimarchi, M. G. Ruocco, L. Reavie, S. Cathelin, B. G. Mar, A. Klinakis, Y. Lukyanov, J. C. Tseng, F. Sen, et al. 2009. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 459: 1000-1004.
30. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R7-R28.
31. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188: 1883-1894.
32. H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
33. Kivisäkk, P., J. Imitola, S. Rasmussen, W. Elyaman, B. Zhu, R. M. Ransohoff, and S. J. Khoury. 2009. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann. Neurol. 65: 457-469.
34. Kawakami, N., S. Lassmann, Z. Li, F. Odoardi, T. Ritter, T. Ziemssen, W. E. Klinkert, J. W. Ellwart, M. Bradl, K. Krivacic, et al. 2004. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199: 185-197.
35. Elyaman, W., E. M. Bradshaw, Y. Wang, M. Oukka, P. Kivisäkk, S. Chiba, H. Yagita, and S. J. Khoury. 2007. JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J. Immunol. 179: 5990-5998.
36. + T-cell responses mediating graft-versus-host disease. Blood 117: 299-308.
37. Tran, I. T., A. R. Sandy, A. J. Carulli, C. Ebens, J. Chung, G. T. Shan, V. Radojcic, A. Friedman, T. Gridley, A. Shelton, et al. 2013. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J. Clin. Invest. 123: 1590-1604.
38. + T cells. J. Immunol. 190: 5818-5828.
39. Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170: 4886-4890.
40. + T cell differentiation. J. Immunol. 177: 7515-7519.
41. Ong, C. T., J. R. Sedy, K. M. Murphy, and R. Kopan. 2008. Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS ONE 3: e2823.
42. Sallusto, F., D. Impellizzieri, C. Basso, A. Laroni, A. Uccelli, A. Lanzavecchia, and B. Engelhardt. 2012. T-cell trafficking in the central nervous system. Immunol. Rev. 248: 216-227.
43. Sheremata, W. A., T. L. Vollmer, L. A. Stone, A. J. Willmer-Hulme, and M. Koller. 1999. A safety and pharmacokinetic study of intravenous natalizumab in patients with MS. Neurology 52: 1072-1074.
44. Tudor, K. S., K. L. Hess, and J.M. Cook-Mills. 2001. Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 15: 196-211.
45. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144: 245-268.